Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 1.79MNet Cash Flow - Investing
VS
Market
Sector
Industry
History
$ 0.2Close
$ 0.04 - $ 0.84 52-Week Range
Ticker Information
Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADAPTIMMUNE THERAPEUTICS PLC - Net Cash Flow - Investing Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADAP - CF - Investing Historical data
| Date | Net Cash Flow - Investing |
|---|---|
| 6/30/2025 | $ 1.79M |
| 3/31/2025 | $ -17.44M |
| 12/31/2024 | $ -58.95M |
| 9/30/2024 | $ 1.08M |
| 6/30/2024 | $ 124.4M |
| 3/31/2024 | $ 127.84M |
| 12/31/2023 | $ 176.54M |
| 9/30/2023 | $ 129.29M |
| 6/30/2023 | $ 100.84M |
| 3/31/2023 | $ 142.25M |
Key Performance Insights, Last 5 Years
- ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) CF - Investing stands at $ -262.85M.
- Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average CF - Investing has been $ 23.08M.
- The median CF - Investing for ADAPTIMMUNE THERAPEUTICS PLC during this period was $ 49.37M
- ADAPTIMMUNE THERAPEUTICS PLC reached its highest CF - Investing over the past 5 years at $ 176.54M.
- The lowest CF - Investing recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe $ -278.92M
ADAPTIMMUNE THERAPEUTICS PLC's CF - Investing vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Investing Benchmarks
Similar metrics to CF - Investing:
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Net Cash Flow - Investment Acquisitions and Disposals - [Cash Flow Statement] A component of cash flow from investing [NCFI], representing the cash inflow (outflow) from disposal (acquisition) of investments. Includes marketable securities and loan originations.
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Net Cash Flow - Exchange Rate Changes on Cash - [Cash Flow Statement] Refers to the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
Definition of Net Cash Flow - Investing
[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].ADAP - Net Cash Flow - Investing, Last 5 years
$ -278.92M
Minimum
Dec 31, 2020
$ 176.54M
Maximum
Dec 31, 2023
$ 23.08M
Average
$ 49.37M
Median
CF - Investing Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
| filtered constituents | 3.17K |
|---|---|
| min | $ -292.23M |
| max | $ 241M |
| average | $ -35.29M |
| median | $ -6.38M |
| std | $ 83.34M |